Back to Search
Start Over
Adrenal cancer: clinical advances
- Source :
- Hormones & cancer, Hormones & cancer, New York, NY : Springer Science + Business Media, 2011, 2 (6), pp.323. ⟨10.1007/s12672-011-0092-4⟩
- Publication Year :
- 2011
- Publisher :
- HAL CCSD, 2011.
-
Abstract
- The purpose of this special edition of Hormones & Cancer is to relay the exciting new developments in the adrenal cancer field that have emerged in the last few years. The very successful 3rd International Adrenal Cancer Symposium: From Molecular Pathogenesis to Clinical Outcome held in Wurzburg, Germany earlier this year served as a backdrop for this project. This meeting followed two highly stimulating International Adrenal Cancer Symposia organized in Ann Arbor (Michigan, USA) and continued to be a key event in the field of adrenal cancer. More than 140 clinicians and investigators from 17 different countries attended the meeting with more than 30 talks covering the whole spectrum of this rare disease. However, rather than compile manuscripts as simple summaries of the symposium to serve as a “proceeding”, we elected to solicit bona fide state of the art “expert reviews” of various aspects of scientific and clinical import in the field of adrenal cancer. All articles were peer reviewed by experts in the endocrine, oncology, and specialized adrenal cancer field. Serendipitously, we were simultaneously given the opportunity to serve as guest editors for two separate “special editions” in both the Endocrine Society/Springer journal Hormones & Cancer and the Elsevier journal Molecular and Cellular Endocrinology. We elected to publish the more clinically relevant articles in Hormones & Cancer and the more basic articles in Molecular and Cellular Endocrinology. Readers should consider these two publications’ companion editions that detail the state of the science and clinical care pertinent to this disease. In Hormones & Cancer, articles are focused on the topics of “Advances in the diagnostic and prognostic markers of adrenocortical carcinoma” (including contributions by Auchus, Papotti et al., Young, Hahner and Sundin, and Deandreis et al.) and “Current and emerging therapies for adrenocortical carcinoma” (with contributions by Baudin et al., Porpiglia et al., Berruti et al., and Demeure et al.). In the companion Molecular and Cellular Endocrinology —Adrenal Cancer: Scientific Advances Special Edition, articles provide a comprehensive view from “Adrenal development—implications for tumorigenesis” (contributions from Simon and Hammer, Gardiner et al., Lauter et al., and de Joussineau et al.) to the “Epidemiology of adrenocortical carcinoma” (contributions by Ribeiro et al., Figueiredo et al., and Almeida and Faria), “Cellular and animal models for adrenocortical carcinoma” (contributions by Wang and Rainey, Else, Luconi and Mannelli, and Wilson and Beuschlein) and “Genetics and genomics of adrenocortical carcinoma” (contributions by Berthon et al., Ribeiro and Latronico, Wasserman et al., Assie et al., and Singh et al.). The editors would like to thank Lisa K. Byrd for her administrative efforts through this process. Together with the companion Adrenal Cancer Special Edition published in Molecular and Cellular Endocrinology, she kept 102 authors informed and on task, handling a total of 25 manuscripts. Without her involvement, this special edition would not have been possible. We hope you will enjoy reading those papers as much as we did while preparing the journal issues.
- Subjects :
- MESH: Carcinoma
Cancer Research
Endocrinology, Diabetes and Metabolism
Adrenal Gland Neoplasms
Library science
[SDV.CAN]Life Sciences [q-bio]/Cancer
030230 surgery
Medical Oncology
MESH: Prognosis
03 medical and health sciences
0302 clinical medicine
Endocrinology
MESH: Molecular Targeted Therapy
Biomarkers, Tumor
medicine
Animals
Humans
Adrenocortical carcinoma
MESH: Animals
Molecular Targeted Therapy
Clinical care
State of the science
MESH: Endocrinology
ComputingMilieux_MISCELLANEOUS
MESH: Medical Oncology
MESH: Humans
Endocrine and Autonomic Systems
Carcinoma
Molecular pathogenesis
Cancer
Prognosis
medicine.disease
MESH: Adrenal Gland Neoplasms
3. Good health
Disease Models, Animal
Cell Transformation, Neoplastic
Oncology
MESH: Cell Transformation, Neoplastic
030220 oncology & carcinogenesis
MESH: Tumor Markers, Biological
MESH: Disease Models, Animal
Psychology
Subjects
Details
- Language :
- English
- ISSN :
- 18688497 and 18688500
- Database :
- OpenAIRE
- Journal :
- Hormones & cancer, Hormones & cancer, New York, NY : Springer Science + Business Media, 2011, 2 (6), pp.323. ⟨10.1007/s12672-011-0092-4⟩
- Accession number :
- edsair.doi.dedup.....f57e42a25f8093de81529861ce410578